Private Equity Profile
In the last 3 years, Medivate Partners has acquired 1 company.
Medivate Partners’ most common sector for investment is life science (100%). The Firm’s most common investment types include growth capital (67%) and buyout (lbo, mbo, mbi) (34%). In total, Medivate Partners has invested in 2 US states and 2 different countries.
In the last 3 years, Medivate Partners has exited 2 companies. The Firm’s most common exit type is trade sale (100%). Medivate Partners’ largest (disclosed) exit occurred in 2021 when it sold Cognate BioServices for $875M.
Join Mergr to view Medivate Partners’ full profile and discover more small private equity firms just like it.
M&A Total Activity5
- M&A Buy Activity3
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 4